Comparative efficacy of axitinib versus sorafenib for advanced renal cell carcinoma

被引：0
|
作者：
不详
机构：
来源：
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH | 2012年 / 1卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：11 / 12
页数：2
相关论文
共 50 条
  • [11] Pharmacokinetics of Neoadjuvant Axitinib Influenced the Efficacy in Patients With Advanced Renal Cell Carcinoma
    Yamamoto, Yoshiaki
    Otori, Toru
    Inoue, Ryo
    Yano, Seiji
    Hirata, Hiroshi
    Matsumoto, Hiroaki
    Matsuyama, Kenji
    Matsuyama, Hideyasu
    JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 60 (02): : 256 - 263
  • [12] Axitinib in advanced renal-cell carcinoma
    Yousaf, Nadia
    Larkin, James
    LANCET ONCOLOGY, 2013, 14 (13): : 1245 - 1246
  • [13] Axitinib for the treatment of advanced renal cell carcinoma
    Akaza, Hideyuki
    Fukuyama, Tomofusa
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (02) : 283 - 297
  • [14] Axitinib: A Review in Advanced Renal Cell Carcinoma
    Keating, Gillian M.
    DRUGS, 2015, 75 (16) : 1903 - 1913
  • [15] Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
    Rini, Brian I.
    Plimack, Elizabeth R.
    Stus, Viktor
    Gafanov, Rustem
    Hawkins, Robert
    Nosov, Dmitry
    Pouliot, Frederic
    Alekseev, Boris
    Soulieres, Denis
    Melichar, Bohuslav
    Vynnychenko, Ihor
    Kryzhanivska, Anna
    Bondarenko, Igor
    Azevedo, Sergio J.
    Borchiellini, Delphine
    Szczylik, Cezary
    Markus, Maurice
    McDermott, Raymond S.
    Bedke, Jens
    Tartas, Sophie
    Chang, Yen-Hwa
    Tamada, Satoshi
    Shou, Qiong
    Perini, Rodolfo F.
    Chen, Mei
    Atkins, Michael B.
    Powles, Thomas
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (12): : 1116 - 1127
  • [16] Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
    Motzer, Robert J.
    Penkov, Konstantin
    Haanen, John
    Rini, Brian
    Albiges, Laurence
    Campbell, Matthew T.
    Venugopal, Balaji
    Kollmannsberger, Christian
    Negrier, Sylvie
    Uemura, Motohide
    Lee, Jae L.
    Vasiliev, Aleksandr
    Miller, Wilson H., Jr.
    Gurney, Howard
    Schmidinger, Manuela
    Larkin, James
    Atkins, Michael B.
    Bedke, Jens
    Alekseev, Boris
    Wang, Jing
    Mariani, Mariangela
    Robbins, Paul B.
    Chudnovsky, Aleksander
    Fowst, Camilla
    Hariharan, Subramanian
    Huang, Bo
    di Pietro, Alessandra
    Choueiri, Toni K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (12): : 1103 - 1115
  • [17] Axitinib: An audit of dose adjustments, tolerability and efficacy in advanced renal cell carcinoma
    Parkar, R.
    Boleti, E.
    ANNALS OF ONCOLOGY, 2018, 29
  • [18] Efficacy of cryoablation combined with sorafenib for the treatment of advanced renal cell carcinoma
    Liu, Changfu
    Cao, Fei
    Xing, Wenge
    Si, Tongguo
    Yu, Haipeng
    Yang, Xueling
    Guo, Zhi
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2019, 36 (01) : 220 - 228
  • [19] Axitinib versus sorafenib as first-line therapy in patients with metastatic renal cell carcinoma (mRCC)
    Hutson, Thomas E.
    Gallardo, Jorge
    Lesovoy, Vladmir
    Al-Shukri, Salman
    Stus, Viktor
    Bair, A. H.
    Rosbrook, Brad
    Bycott, Paul W.
    Tarazi, Jamal Christo
    Kim, Sinil
    Vogelzang, Nicholas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [20] Axitinib: A Review of its Safety and Efficacy in the Treatment of Adults with Advanced Renal Cell Carcinoma
    Gross-Goupil, Marine
    Francois, Louis
    Quivy, Amandine
    Ravaud, Alain
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2013, 7 : 269 - 277
12345